Transcatheter heart valve therapies for all heart valves: from an innovation strategy to mainstream therapy
Sponsored by Edwards Lifesciences
- To learn about the Edwards Lifesciences innovation pipeline for the aortic, mitral, tricuspid and pulmonary valve
- To understand the latest and upcoming evidence in the aortic field
- To learn about the economic value of innovative technology
The aortic valve: standard of care for intermediate-risk, high-risk and inoperable patients; expanded indication studies underway
What is the value of innovation in less invasive procedures to patients and healthcare systems?